{"id":"https://openalex.org/W2890660749","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps2619","title":"First-in-human phase 1-2A study of CB-103, an oral Protein-Protein Interaction Inhibitor targeting pan-NOTCH signalling in advanced solid tumors and blood malignancies.","display_name":"First-in-human phase 1-2A study of CB-103, an oral Protein-Protein Interaction Inhibitor targeting pan-NOTCH signalling in advanced solid tumors and blood malignancies.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2890660749","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps2619","mag":"2890660749"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.tps2619","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps2619","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps2619","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090108117","display_name":"Jos\u00e9 Manuel P\u00e9rez-Garc\u00eda","orcid":"https://orcid.org/0000-0003-4238-2046","observed_orcids":["https://orcid.org/0000-0003-4238-2046","https://orcid.org/0009-0004-2204-2014"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jose Manuel Perez Garcia","raw_affiliation_strings":["Medical Oncology Department (IOB), Quiron Hospital, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department (IOB), Quiron Hospital, Barcelona, Spain;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051629490","display_name":"Javier Cort\u00e9s","orcid":"https://orcid.org/0000-0001-7623-1583","observed_orcids":["https://orcid.org/0000-0001-7623-1583"]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Cort\u00e9s","raw_affiliation_strings":["Ramon y Cajal University Hospital, Madrid, and Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ramon y Cajal University Hospital, Madrid, and Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;","institution_ids":["https://openalex.org/I4210161852","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048622832","display_name":"Anastasios Stathis","orcid":"https://orcid.org/0000-0002-2859-7529","observed_orcids":["https://orcid.org/0000-0002-2859-7529"]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Anastasios Stathis","raw_affiliation_strings":["IOSI - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IOSI - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024949273","display_name":"Rogier Mous","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Rogier Mous","raw_affiliation_strings":["UMC Utrecht Cancer Center, Utrecht, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UMC Utrecht Cancer Center, Utrecht, Netherlands;","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061314243","display_name":"Elena L\u00f3pez-Miranda","orcid":"https://orcid.org/0000-0002-2253-739X","observed_orcids":["https://orcid.org/0000-0002-2253-739X"]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elena L\u00f3pez-Miranda","raw_affiliation_strings":["Ram\u00f3n y Cajal H\u00f3spital, Madrid, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ram\u00f3n y Cajal H\u00f3spital, Madrid, Spain;","institution_ids":["https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112385468","display_name":"Anal\u00eda Azaro","orcid":"https://orcid.org/0000-0001-6852-4925","observed_orcids":["https://orcid.org/0000-0001-6852-4925"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Anal\u00eda Azaro","raw_affiliation_strings":["Medical Oncology Department, Vall d\u2019Hebron University Hospital; Molecular Therapeutics Research Group, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Vall d\u2019Hebron University Hospital; Molecular Therapeutics Research Group, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050247782","display_name":"Sofia Genta","orcid":"https://orcid.org/0000-0001-8441-2456","observed_orcids":["https://orcid.org/0000-0001-8441-2456"]},"institutions":[{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Sofia Genta","raw_affiliation_strings":["Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;","institution_ids":["https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081259888","display_name":"Paolo Giovanni Nuciforo","orcid":"https://orcid.org/0000-0003-1380-0990","observed_orcids":["https://orcid.org/0000-0003-1380-0990"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Paolo Nuciforo","raw_affiliation_strings":["Molecular Pathology Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pathology Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain;","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071876778","display_name":"Ana P. Vivancos","orcid":"https://orcid.org/0000-0003-2888-6512","observed_orcids":["https://orcid.org/0000-0003-2888-6512"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Vivancos","raw_affiliation_strings":["Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain;","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007020035","display_name":"Renata Ferrarotto","orcid":"https://orcid.org/0000-0002-3561-215X","observed_orcids":["https://orcid.org/0000-0002-3561-215X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renata Ferrarotto","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066518317","display_name":"Francesco Bertoni","orcid":"https://orcid.org/0000-0001-5637-8983","observed_orcids":["https://orcid.org/0000-0001-5637-8983","https://orcid.org/0000-0002-7301-1208"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]},{"id":"https://openalex.org/I57201433","display_name":"Universit\u00e0 della Svizzera italiana","ror":"https://ror.org/03c4atk17","country_code":"CH","type":"education","lineage":["https://openalex.org/I57201433"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Francesco Bertoni","raw_affiliation_strings":["Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e0 della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland;","institution_ids":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015790909","display_name":"Davide Rossi","orcid":"https://orcid.org/0000-0002-2837-1597","observed_orcids":["https://orcid.org/0000-0002-2837-1597"]},"institutions":[{"id":"https://openalex.org/I4210101830","display_name":"Institute of Oncology Research","ror":"https://ror.org/01dpyn972","country_code":"CH","type":"facility","lineage":["https://openalex.org/I4210101830","https://openalex.org/I57201433"]},{"id":"https://openalex.org/I4404532900","display_name":"Istituto Oncologico della Svizzera Italiana","ror":"https://ror.org/04tty5b50","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210095212","https://openalex.org/I4404532900"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Davide Rossi","raw_affiliation_strings":["Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;","institution_ids":["https://openalex.org/I4210101830","https://openalex.org/I4404532900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063295871","display_name":"Nicole Spardy Burr","orcid":"https://orcid.org/0009-0004-7581-8947","observed_orcids":["https://orcid.org/0009-0004-7581-8947"]},"institutions":[{"id":"https://openalex.org/I4210144988","display_name":"Adenoid Cystic Carcinoma Research Foundation","ror":"https://ror.org/04fafj987","country_code":"US","type":"other","lineage":["https://openalex.org/I4210144988"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Spardy Burr","raw_affiliation_strings":["Adenoid Cystic Carcinoma Research Foundation, Needham, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adenoid Cystic Carcinoma Research Foundation, Needham, MA;","institution_ids":["https://openalex.org/I4210144988"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082719401","display_name":"Oliver Sch\u00f6nborn\u2010Kellenberger","orcid":"https://orcid.org/0000-0002-5266-7881","observed_orcids":["https://orcid.org/0000-0002-5266-7881"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver Sch\u00f6nborn-Kellenberger","raw_affiliation_strings":["Cogitars GmbH, Heidelberg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cogitars GmbH, Heidelberg, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110032422","display_name":"Karin M. Jorga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karin Jorga","raw_affiliation_strings":["Karin Jorga Life Science Consulting GmbH, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karin Jorga Life Science Consulting GmbH, Basel, Switzerland;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089250017","display_name":"Laura Beni","orcid":"https://orcid.org/0009-0000-1336-6165","observed_orcids":["https://orcid.org/0009-0000-1336-6165"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Beni","raw_affiliation_strings":["Cellestia Biotech AG, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellestia Biotech AG, Basel, Switzerland;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036605384","display_name":"Rajwinder Lehal","orcid":"https://orcid.org/0000-0002-9508-7553","observed_orcids":["https://orcid.org/0000-0002-9508-7553"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rajwinder Lehal","raw_affiliation_strings":["Cellestia Biotech AG, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellestia Biotech AG, Basel, Switzerland;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063631964","display_name":"Michael Bauer","orcid":"https://orcid.org/0009-0001-4193-2731","observed_orcids":["https://orcid.org/0009-0001-4193-2731"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Bauer","raw_affiliation_strings":["Cellestia Biotech AG, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellestia Biotech AG, Basel, Switzerland;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Dirk Weber","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dirk Weber","raw_affiliation_strings":["Cellestia Biotech AG, Basel, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellestia Biotech AG, Basel, Switzerland;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059711568","display_name":"Elena Garralda","orcid":"https://orcid.org/0000-0002-4412-7842","observed_orcids":["https://orcid.org/0000-0002-4412-7842"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elena Garralda","raw_affiliation_strings":["Medical Oncology Department, Vall d\u2019Hebron University Hospital; Molecular Therapeutics Research Group, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Vall d\u2019Hebron University Hospital; Molecular Therapeutics Research Group, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain;","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"TPS2619","last_page":"TPS2619"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10268","display_name":"Developmental Biology and Gene Regulation","score":0.3788999915122986,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10268","display_name":"Developmental Biology and Gene Regulation","score":0.3788999915122986,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.10350000113248825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.06800000369548798,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/notch-signaling","display_name":"Notch signaling","score":0.8220000267028809},{"id":"https://openalex.org/keywords/protein-protein-interaction-inhibitors","display_name":"protein-protein interaction inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7459999918937683},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.949999988079071},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7269999980926514},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9290000200271606},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9259999990463257},{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.7350000143051147},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.7429999709129333},{"id":"https://openalex.org/keywords/ccnd1","display_name":"CCND1","score":0.9520000219345093},{"id":"https://openalex.org/keywords/hes1","display_name":"Hes1","score":0.9940000176429749}],"concepts":[{"id":"https://openalex.org/C161879069","wikidata":"https://www.wikidata.org/wiki/Q904082","display_name":"Notch signaling pathway","level":3,"score":0.8233177661895752},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7899748086929321},{"id":"https://openalex.org/C2780283210","wikidata":"https://www.wikidata.org/wiki/Q18027301","display_name":"HES1","level":4,"score":0.5608864426612854},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44433024525642395},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.43803009390830994},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4345976710319519},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4017542898654938},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36820337176322937},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3320375084877014},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.25590965151786804},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.13793882727622986},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12608671188354492},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.tps2619","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps2619","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps2619","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3088249195","https://openalex.org/W3170565877","https://openalex.org/W2786816942","https://openalex.org/W2793012390","https://openalex.org/W4386099113","https://openalex.org/W2623532793","https://openalex.org/W2740035020","https://openalex.org/W2886806434","https://openalex.org/W2954493985","https://openalex.org/W2501839333"],"abstract_inverted_index":{"TPS2619":[0],"Background:":[1],"NOTCH":[2,23,42,68,79,88,92,251,272],"signalling":[3,24,89],"is":[4,12,25,44,53,123,148,156,184],"a":[5,54,124,158],"key":[6],"development":[7],"pathway":[8,252,273],"whose":[9],"aberrant":[10],"activation":[11,253],"recognised":[13],"to":[14,46,48,63,76,149,189,316],"play":[15],"an":[16,33],"oncogenic":[17,34],"role":[18],"in":[19,71,102,114,134,186,260,265,284,322,324],"human":[20],"cancers.":[21],"When":[22],"inappropriately":[26],"activated":[27],"by":[28],"genetic":[29,274],"alterations,":[30],"it":[31],"becomes":[32],"driver":[35],"for":[36,181,271],"NOTCH-dependent":[37],"cancers,":[38],"while":[39,263],"upregulation":[40],"of":[41,50,66,78,87,91,94,141,145,172,192,206,214,250,282],"receptors":[43],"linked":[45],"resistance":[47],"standard":[49],"care.":[51],"CB-103":[52,96,283],"new":[55],"small":[56],"molecule":[57],"protein-protein":[58],"interaction":[59],"(PPI)":[60],"inhibitor":[61],"able":[62],"target":[64,80],"assembly":[65],"the":[67,72,151],"transcription":[69],"complex":[70],"cell":[73],"nucleus":[74],"leading":[75],"downregulation":[77],"genes":[81],"(c-MYC,":[82],"CCND1,":[83],"HES1)":[84],"and":[85,100,113,168,211,219,230,244,320],"inhibition":[86],"independently":[90],"mechanisms":[93],"activation.":[95],"has":[97,164],"demonstrated":[98],"efficacy":[99,281],"tolerability":[101],"different":[103,288],"preclinical":[104],"tumor":[105],"models":[106],"derived":[107],"from":[108,116],"various":[109],"NOTCH-driven":[110],"cancer":[111,318],"indications":[112,289],"blood":[115,231],"NOTCH-activated":[117],"leukemia":[118],"pts.":[119],"Methods:":[120],"This":[121],"study":[122,133],"multi-centre,":[125],"open":[126],"label,":[127],"non-randomised,":[128],"phase":[129,146,187,261,266],"1-2A":[130],"dose":[131,155,182,258,296],"escalation":[132,183],"adult":[135],"patients":[136],"(pts),":[137],"with":[138,300,309],"expansion":[139,285],"arms":[140,286],"oral":[142],"CB-103.":[143],"Aim":[144],"1":[147,188,203,213,313],"find":[150],"MTD/RP2D.":[152,193],"The":[153],"starting":[154],"targeting":[157],"plasma":[159],"exposure":[160],"(daily":[161],"AUC)":[162],"that":[163],"reasonable":[165],"safety":[166],"margin":[167],"allows":[169],"reliable":[170],"determination":[171,191],"pharmacokinetics":[173],"(PK).":[174],"An":[175],"adaptive":[176],"Bayesian":[177,291],"logistic":[178],"regression":[179],"model":[180],"implemented":[185],"guide":[190],"Full":[194],"PK":[195,243],"sampling":[196],"profiles":[197],"will":[198,268,278],"be":[199,239,269],"taken":[200],"on":[201,225,242,304],"days":[202],"&":[204],"8":[205],"cycle":[207,215],"one":[208],"(28":[209],"days)":[210],"day":[212],"two.":[216],"NOTCH-related":[217],"PD":[218],"Biomarker":[220],"exploratory":[221],"analyses":[222],"are":[223,255],"planned":[224],"tumour":[226],"biopsies,":[227],"hair":[228],"follicles":[229],"samples":[232],"(liquid":[233],"biopsy).":[234],"Administration":[235],"schedule":[236],"(once-daily)":[237],"may":[238],"adapted":[240],"depending":[241],"safety.":[245],"3-6":[246],"eligible":[247],"pts":[248,264,307],"regardless":[249],"status":[254],"enrolled":[256],"per":[257],"group":[259,297],"1,":[262],"2A":[267,277],"selected":[270],"alterations.":[275],"Phase":[276],"assess":[279],"preliminary":[280],"across":[287],"using":[290],"design.":[292],"Enrolment":[293],"into":[294],"1st":[295],"(15mg)":[298],"started":[299],"first":[301,326],"pt":[302],"treated":[303],"20Dec17:":[305],"7":[306],"registered":[308],"2":[310],"screen":[311],"failures,":[312],"discontinued":[314],"due":[315],"early":[317],"progression":[319],"4":[321],"treatment":[323,327],"their":[325],"cycle.":[328],"Clinical":[329],"trial":[330],"information:":[331],"NCT03422679.":[332]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2018-09-27T00:00:00"}